Cardinal Health, Inc. $CAH Position Raised by BI Asset Management Fondsmaeglerselskab A S

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

BI Asset Management Fondsmaeglerselskab A S increased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 102.7% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 183,175 shares of the company's stock after purchasing an additional 92,795 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S owned 0.08% of Cardinal Health worth $25,236,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Principal Financial Group Inc. increased its position in Cardinal Health by 5.3% during the 1st quarter. Principal Financial Group Inc. now owns 315,817 shares of the company's stock worth $43,510,000 after purchasing an additional 15,956 shares in the last quarter. Kingswood Wealth Advisors LLC grew its position in Cardinal Health by 17.2% in the first quarter. Kingswood Wealth Advisors LLC now owns 3,119 shares of the company's stock valued at $429,000 after acquiring an additional 457 shares in the last quarter. Assenagon Asset Management S.A. grew its position in Cardinal Health by 25.8% in the first quarter. Assenagon Asset Management S.A. now owns 13,147 shares of the company's stock valued at $1,811,000 after acquiring an additional 2,694 shares in the last quarter. Golden State Wealth Management LLC grew its position in Cardinal Health by 569.5% in the first quarter. Golden State Wealth Management LLC now owns 395 shares of the company's stock valued at $54,000 after acquiring an additional 336 shares in the last quarter. Finally, North Capital Inc. acquired a new stake in Cardinal Health in the first quarter valued at approximately $83,000. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Stock Performance

Shares of CAH stock traded down $3.5270 during mid-day trading on Friday, reaching $148.0430. 2,685,985 shares of the company were exchanged, compared to its average volume of 2,527,078. Cardinal Health, Inc. has a fifty-two week low of $106.54 and a fifty-two week high of $168.44. The company has a market capitalization of $35.35 billion, a P/E ratio of 22.95, a P/E/G ratio of 1.28 and a beta of 0.67. The business's 50 day simple moving average is $159.02 and its 200 day simple moving average is $145.33.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter last year, the company earned $1.84 earnings per share. The business's quarterly revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a dividend of $0.5107 per share. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.4%. Cardinal Health's dividend payout ratio (DPR) is 31.63%.

Analyst Ratings Changes

CAH has been the subject of several recent research reports. Wall Street Zen downgraded shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 2nd. Wells Fargo & Company reaffirmed an "overweight" rating and issued a $185.00 price objective (up previously from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Citigroup reaffirmed a "neutral" rating and issued a $170.00 price objective (up previously from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Robert W. Baird increased their price objective on shares of Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a research report on Wednesday, August 13th. Finally, UBS Group reaffirmed a "buy" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $163.20.

Insider Activity

In related news, insider Michelle D. Greene sold 13,500 shares of the firm's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the transaction, the insider directly owned 14,976 shares in the company, valued at $2,228,728.32. This trade represents a 47.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Jessica L. Mayer sold 38,078 shares of the firm's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the transaction, the insider owned 48,457 shares in the company, valued at $7,211,370.74. This trade represents a 44.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 271,676 shares of company stock valued at $40,489,525 over the last three months. 0.09% of the stock is currently owned by company insiders.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.